• Substance P (B6620): Assay Workflow Guide

  2026-09-09

  This scenario-based guide explains how Substance P (SKU B6620) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing receptor biology with assay artifacts. It covers aqueous preparation, peptide stability, controls, data interpretation, and practical vendor-selection criteria for reproducible neurokinin-1 research.

• HIV-1 Protease Autoprocessing for HTS

  2026-09-08

  Huang and colleagues developed a cell-based AlphaLISA platform that measures HIV-1 protease precursor autoprocessing and supports high-throughput inhibitor screening. The assay selectively identified known HIV protease inhibitors, reproduced resistance-associated phenotypes, and provides a functional complement to conventional assays focused on mature protease binding.

• Isradipine (Dynacirc) Research Workflows

  2026-09-08

  Isradipine (Dynacirc) provides a practical way to interrogate L-type calcium channel function across neuronal and vascular models. This guide pairs formulation and assay workflows with pharmacological safeguards inspired by v-Agatoxin-IVA research, helping distinguish true L-type effects from broader calcium-channel responses.

• EZ Cap™ EPO mRNA: Design for Better Assays

  2026-09-07

  EZ Cap™ EPO mRNA combines Cap 1 capping, pseudouridine, and a poly(A) tail for controlled human erythropoietin mRNA expression. This article provides an assay-first framework for connecting RNA chemistry, nanoparticle delivery, translational readouts, and study-specific controls.

• MLKL Polymerization, Lysosomal LMP, and Necroptosis

  2026-09-07

  The reference study identifies lysosomal membrane permeabilization as a mechanistic step linking MLKL polymerization to necroptotic cell death. Its imaging, inhibition, knockdown, and MLKL-domain experiments place cathepsin B release downstream of lysosomal damage and provide a framework for dissecting regulated cell death with orthogonal assays.

• Phenytoin for Sodium Channel and Myelin Assays

  2026-09-05

  Use Phenytoin to connect sodium-channel activity measurements with live myelin-remodeling experiments, while preserving vehicle, imaging, and electrophysiology controls. This workflow emphasizes fresh preparation, concentration scouting, and longitudinal endpoints rather than treating reduced activity as a direct proxy for myelin repair.

• AL-8810 for FP Receptor Assay Design

  2026-09-04

  This scenario-driven guide explains how AL-8810 (SKU B4575) can clarify FP receptor-dependent effects in viability, proliferation, cytotoxicity, MMP-2, and ERK1/2 assays. It connects documented potency and handling characteristics with practical controls, interpretation strategies, and vendor-selection criteria.

• Tolazoline and Translational Control of Insulin Signaling

  2026-09-04

  Tolazoline is more than a conventional α2-adrenergic receptor antagonist: its concentration-dependent effects on β-cell ATP-sensitive potassium channels create both an experimental opportunity and a selectivity challenge. This thought-leadership guide connects Tolazoline pharmacology with findings from an Alzheimer’s disease insulin-signaling study, while defining practical boundaries for islet, airway, and exploratory neuroendocrine translation.

• MG-132 Workflows for Proteasome and Apoptosis Studies

  2026-09-03

  MG-132 (Z-LLL-al) provides a practical, cell-permeable way to connect proteasome blockade with apoptosis, cell-cycle changes, and oxidative stress. This guide translates recent chondrosarcoma metabolism findings into controlled MG-132 assay designs, dose-finding workflows, and troubleshooting decisions.

• Mavorixafor and the CXCR4 Translational Edge

  2026-09-03

  A mechanistic and strategic guide to using AMD-070 hydrochloride as a CXCR4 antagonist in WHIM syndrome, hematologic research, and carefully bounded anti-HIV research programs.

• ECL Western Blotting Substrate: Practical Guide

  2026-09-02

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for chemiluminescent immunoblots. It is intended for HRP-based Western blot imaging with X-ray film or CCD cameras, not for fluorescent or radioisotopic detection.

• Hexose Diphosphate for Metabolic Research

  2026-09-02

  Hexose diphosphate supports practical workflows spanning glycolytic enzyme assays, cardiovascular ischemia research, and inflammation-linked metabolic studies. This guide shows how to handle the water-soluble hexose phosphate, build concentration-response experiments, and interpret results without confusing it with phosphoenolpyruvate.

• BAPTA and the Calcium Decision Point in Toxicology

  2026-09-01

  BAPTA is more than a calcium chelator: it is a causal probe for determining whether intracellular Ca2+ signaling drives toxicant-induced apoptosis. This article translates recent IP3R/Ca2+/STAT3 findings into a practical framework for mechanistic validation, assay design, and translational decision-making.

• Epoxomicin in Proteasome-Dependent Inflammation

  2026-09-01

  Epoxomicin provides a selective, irreversible way to test whether protein loss is proteasome-dependent, making it useful for RIPK3 stability, viral inflammation, and broader ubiquitin-proteasome pathway research. This guide translates the vIRD–RIPK3 findings into practical assay design, dosing, controls, and troubleshooting strategies.

• Nifedipine (BAY-a-1040) Research Workflows

  2026-08-31

  Use Nifedipine (BAY-a-1040) to create controlled L-type calcium influx inhibition in contraction, viability, transport, and fungal-growth assays. This practical guide also shows how to pair calcium perturbation with iron metabolism and PXR-linked liver studies without confusing nifedipine with the PXR agonist used in the reference rat model.

7798 records 1/520 page Next 12345 下5页 Last page